Replies to post #6455 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Let me guess...another stock symbol reference?

To answer your question/concern it must be first posed by a question.

What were their clinical trial results?

It's my understanding Algernon's NP-120 reduced fibrosis by 110% over the current best in class.

Furthermore, NP-120 is not a one trick pony.

I have a post here today with NP-120 targeted diseases:

Idiopathic Pulmonary Fibrosis
Acute Lung Injury
Chronic Cough
Influenza
Covid-19

Algernon is on the brink of Prescription & Over-The-Counter medications.

Chronic & Acute.

Hmmm?

OAN: Yeah! Let's get this money-medchem.

/////AMG